Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Blog
Podcast
Product Guide
Career Quest
Drug Approval
Blog Post
FDA Approves Genentech’s Evrysdi for Treatment of SMA in Pediatric and Adult Patients
By
MDA Staff
|
August 7, 2020
Blog Post
FDA Approves ITF Pharma’s Tiglutik via PEG Tube for the Treatment of ALS
By
Jeanene Swanson
|
December 20, 2019
Blog Post
FDA Approves Sarepta Therapeutics’ Vyondys 53 for Treatment of DMD Amenable to Exon 53 Skipping
By
Jeanene Swanson
|
December 13, 2019
Blog Post
FDA Approves Aquestive Therapeutics’ Exservan for the Treatment of ALS
By
Jeanene Swanson
|
December 6, 2019
Blog Post
Biogen Announces Positive Long-Term Results from Phase 2 Study of Spinraza to Treat SMA in Pre-Symptomatic Infants
By
Jeanene Swanson
|
August 21, 2019
Blog Post
Simply Stated: What is Spinal Muscular Atrophy?
By
Jeanene Swanson
|
August 15, 2019
Featured Article
Ongoing Clinical Trials
By
Ori Rokach
|
July 15, 2019
Featured Article
These 7 Things Can Help You Understand Gene Targeting Therapy
By
Amy Madsen
|
July 15, 2019
Blog Post
Simply Stated: What is Myasthenia Gravis?
By
Jeanene Swanson
|
July 2, 2019
Blog Post
FDA Approves PTC Therapeutics’ Emflaza for the Treatment of DMD in Patients Between 2 and 5 Years Old
By
Jeanene Swanson
|
June 10, 2019
« Previous
1
2
3
4
5
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
